局部晚期非小细胞肺癌调强放化疗后急性食管毒性NTCP模型的外部验证
该研究在来自四家荷兰机构的五个队列共603例局部晚期非小细胞肺癌患者中,外部验证了既往建立的预测≥2级急性食管毒性(AET)的多变量正常组织并发症概率(NTCP)模型。模型在三个队列中区分度与训练队列相似(AUC 0.81–0.89 vs 0.84),在两个接受明显不同治疗的队列中区分度差(AUC 0.64和0.63);作者建议临床使用前在本地队列中验证区分度与(再)校准性能。
要点
- 四个验证队列≥2级AET发生率高于训练队列(49.3–70.2% vs 35.6%),一个队列低于训练队列(21.7%,p<0.001)。
- 三个队列区分度与训练队列相似(AUC 0.81–0.89 vs 0.84),两个队列区分度差(AUC 0.64和0.63)。
- 两个队列校准尚可,再校准改善了三个区分度良好队列的性能,但未改善两个区分度差队列的性能。
核心结论
- 该NTCP模型在五个患者队列中的三个(AUC≥0.80)成功验证,在两个接受明显不同治疗的队列中表现不佳。
- 作者建议在临床实践中应用该模型前,在本地队列中验证区分度与(再)校准性能。
研究设计与样本
- 外部验证研究,纳入来自四家荷兰机构五个队列(A–E)的603例局部晚期非小细胞肺癌患者。
- 使用含同步放化疗、食管平均剂量、性别和临床肿瘤分期预测因子的NTCP模型估计每例患者≥2级AET风险,并评估模型区分度与(再)校准性能。
主要发现
- 四个验证队列(A、B、D、E)≥2级AET发生率高于训练队列(49.3–70.2% vs 35.6%),其中一个队列为边缘显著,三个队列为高度显著。
- 队列C的≥2级AET发生率低于训练队列(21.7%,p<0.001)。
- 三个队列(A–C)的区分度与训练队列相似(AUC 0.81–0.89 vs 0.84)。
- 两个队列(D–E)的模型区分度差(AUC 0.64和0.63)。
- 两个队列(A–B)校准性能尚可,再校准进一步改善了三个区分度良好队列(A–C)的性能,但未改善两个区分度差队列(D–E)的性能。
关键数值与推荐
- 模型预测因子包括同步放化疗、食管平均剂量、性别和临床肿瘤分期。
- 模型验证成功标准为三个队列AUC≥0.80(实际AUC 0.81–0.89)。
临床怎么用
- 作者建议在临床实践中应用该模型前,在本地队列中验证区分度与(再)校准性能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: We externally validated a previously established multivariable normal-tissue complication probability (NTCP) model for Grade ≥2 acute esophageal toxicity (AET) after intensity-modulated (chemo-)radiotherapy or volumetric-modulated arc therapy for locally advanced non-small cell lung cancer. MATERIALS AND METHODS: A total of 603 patients from five cohorts (A-E) within four different Dutch institutes were included. Using the NTCP model, containing predictors concurrent chemoradiotherapy, mean esophageal dose, gender and clinical tumor stage, the risk of Grade ≥2 AET was estimated per patient and model discrimination and (re)calibration performance were evaluated. RESULTS: Four validation cohorts (A, B, D, E) experienced higher incidence of Grade ≥2 AET compared to the training cohort (49.3-70.2% vs 35.6%; borderline significant for one cohort, highly significant for three cohorts). Cohort C experienced lower Grade ≥2 AET incidence (21.7%, p < 0.001). For three cohorts (A-C), discriminative performance was similar to the training cohort (area under the curve (AUC) 0.81-0.89 vs 0.84). In the two remaining cohorts (D-E) the model showed poor discriminative power (AUC 0.64 and 0.63). Reasonable calibration performance was observed in two cohorts (A-B), and recalibration further improved performance in all three cohorts with good discrimination (A-C). Recalibration for the two poorly discriminating cohorts (D-E) did not improve performance. CONCLUSIONS: The NTCP model for AET prediction was successfully validated in three out of five patient cohorts (AUC ≥0.80). The model did not perform well in two cohorts, which included patients receiving substantially different treatment. Before applying the model in clinical practice, validation of discrimination and (re)calibration performance in a local cohort is recommended.
引用
- Dankers FJWM, Wijsman R, Troost EGC, et al. External validation of an NTCP model for acute esophageal toxicity in locally advanced NSCLC patients treated with intensity-modulated (chemo-)radiotherapy. Radiother Oncol. 2018. PMID: 30241789. doi:10.1016/j.radonc.2018.07.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。